Two promoters of Cipla Ltd on Tuesday divested shares worth over Rs 1,835.6 crore in the firm, through open market transactions. This represents 2.5 per cent of the total shareholding of the comp...

Drug major Cipla, which is not new to churn in its top deck, on Friday saw another exit when its global chief financial officer Kedar Upadhye resigned. In 2020, Nikhil Chopra, the chief executive of ...

India has added two new vaccines and an early-use anti-viral drug to its armoury to fight Covid-19, all three products based on core technologies developed in the US but produced in India. The Centra...

Calcutta should avoid London’s mistake of allowing too many basement structures because there is nowhere for the water to escape after heavy rains. Last month, London had two flash floods which ...

Engineering and construction giant Larsen & Toubro (L&T) on Friday reported an 11.3 per cent rise in consolidated net profit at Rs 3,820.16 crore for the March quarter of 2020-21 on the back o...

Eli Lilly and Company on Monday said it has inked voluntary licensing agreements with three Indian pharmaceutical firms — Sun Pharma, Cipla and Lupin — to expedite the availability of its ...

...

Pharmaceutical major Cipla has seen three major exits that include  Nikhil Chopra, CEO of its India business, Nikhil Lalwani, who led its US business, and Kunal Khanna, head of the chronic and em...

The 1702 chair in chemistry at Cambridge is being renamed after Yusuf Hamied, head of the Indian pharmaceutical firm Cipla, the university has announced.“The chair will now be known as the Yusuf Ham...

When a vaccine for coronavirus is developed, companies in India will be manufacturing it both for the domestic market and for the world, according to Dr Yusuf Hamied, chairman of the pharma giant Cipl...